Huntington National Bank Takes $42,000 Position in agilon health, inc. (NYSE:AGL)

Huntington National Bank bought a new position in agilon health, inc. (NYSE:AGLFree Report) in the fourth quarter, Holdings Channel reports. The firm bought 21,900 shares of the company’s stock, valued at approximately $42,000.

Other large investors also recently bought and sold shares of the company. Oak Thistle LLC acquired a new stake in shares of agilon health during the fourth quarter worth $25,000. Ieq Capital LLC purchased a new position in agilon health in the 4th quarter worth $26,000. Signaturefd LLC lifted its position in agilon health by 143.0% during the 4th quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock worth $27,000 after acquiring an additional 8,467 shares during the period. Raymond James Financial Inc. purchased a new stake in agilon health during the 4th quarter valued at about $33,000. Finally, Symphony Financial Services Inc. increased its holdings in shares of agilon health by 44.3% in the fourth quarter. Symphony Financial Services Inc. now owns 23,000 shares of the company’s stock valued at $44,000 after purchasing an additional 7,058 shares during the period.

Analyst Ratings Changes

AGL has been the topic of a number of recent research reports. Sanford C. Bernstein upped their target price on agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a research report on Wednesday, January 15th. Citigroup upgraded shares of agilon health from a “sell” rating to a “neutral” rating and increased their price objective for the stock from $1.75 to $2.25 in a research note on Friday, January 10th. Royal Bank of Canada boosted their target price on shares of agilon health from $3.00 to $3.50 and gave the company an “outperform” rating in a research report on Wednesday, February 26th. Stifel Nicolaus increased their price target on agilon health from $2.00 to $3.00 and gave the stock a “hold” rating in a research report on Wednesday, February 26th. Finally, Needham & Company LLC restated a “hold” rating on shares of agilon health in a research note on Friday, March 21st. Two equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $3.95.

Get Our Latest Stock Analysis on AGL

agilon health Stock Up 2.3 %

AGL opened at $4.25 on Tuesday. The company has a market cap of $1.75 billion, a PE ratio of -4.52 and a beta of 0.38. agilon health, inc. has a twelve month low of $1.50 and a twelve month high of $7.73. The company has a 50-day moving average price of $3.76 and a 200 day moving average price of $2.99. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health Company Profile

(Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Featured Articles

Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for agilon health, inc. (NYSE:AGLFree Report).

Institutional Ownership by Quarter for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.